Home > Insider Trading > Filing (0001209191-14-072447)

Filing Details

Accession Number:: 0001209191-14-072447
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-02 17:53:28
Reporting Period:: 2014-11-28

Filing Date:: 2014-12-02
Accepted Time:: 2014-12-02 17:53:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
923421	John L Wilkerson	Elizabeth House, 9 Castle Street St Helier Y9 JE2 3RT		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2014-11-28	145,473	$9.50	5,239,293	No	4	P	Indirect	By Galen Partners V LP
Ordinary Shares	Acquisiton	2014-11-28	12,422	$9.50	447,400	No	4	P	Indirect	By Galen Partners InternationalV LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Galen Partners V LP
No	4	P	Indirect	By Galen Partners InternationalV LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	150,704	Indirect	Galen Management, LLC

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Employee Stock Option (right to buy)	$8.00		2024-04-29	3,500	3,500	Direct
Ordinary Shares	Ordinary Share Warrants	$0.00	2014-07-24	2015-10-25	230,331	287,914	Indirect
Ordinary Shares	Ordinary Share Warrants	$0.00	2014-07-24	2015-10-25	19,669	24,586	Indirect
Ordinary Shares	Ordinary Share Option (right to buy)	$9.95		2024-10-31	5,025	5,025	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-04-29	3,500	3,500	Direct
2015-10-25	230,331	287,914	Indirect
2015-10-25	19,669	24,586	Indirect
2024-10-31	5,025	5,025	Direct

Footnotes

In connection with Quotient Limited's initial public offering, 287,914 units were purchased by Galen Partners V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consisted of one Ordinary Share andone warrant to purchase 0.8 of one Ordinary Share.The Ordinary Shares and warrants comprising the units began trading separately on May 24, 2014, Each warrant is exercisable until 5:30 p.m. on October25, 2015 at an exercise price of $8.80 per Ordinary Share.
Consists solely of 5,239,293 ordinary shares held of record by Galen Partners V LP, 447,400 ordinary shares held of record by Galen Partners International V LP and 150,704 ordinary shares held ofrecord by Galen Management, LLC (collectively, "Galen Partners"), as applicable. John Wilkerson along with David W. Jahns, and Zubeen Shroff exercise voting, investment and dispositive rights over thesecurities held of record by Galen Partners. Mr. Wilkerson disclaims beneficial ownership of these ordinary shares, except to the extent of his proportionate pecuniary interest in such shares.
In connection with Quotient Limited's initial public offering, 24,586 units were purchased by Galen Partners International V LP on 4/30/2014 at a price of $8.00 per unit. Each unit consists of one OrdinaryShare and one warrant to purchase 0.8 of one Ordinary Share. The Ordinary Shares and warrants comprising the units began trading separately on May 24, 2014, Each warrant is exercisable until 5:30 p.m.on October 25, 2015 at an exercise price of $8.80 per Ordinary Share.
The option becomes exercisable in three equal annual installments beginning April 29, 2015.
The option vests and becomes exercisable in three equal installments beginning October 31, 2014.
The ordinary shares were acquired in connection with the issuer's private placement. Galen Partners V LP acquired 145,473 ordinary shares and Galen Partners International V LP acquired 12,422 ordinary shares.